repaglinide has been researched along with Dysphagia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Allah, FI; El-Nabarawi, MA; Elhabal, SF; Fouad, SA; Gebril, MI; Teaima, MH | 1 |
1 other study(ies) available for repaglinide and Dysphagia
| Article | Year |
|---|---|
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats.
Topics: Animals; Blood Glucose; Deglutition Disorders; Excipients; Hypoglycemic Agents; Rats; Solubility; Tablets | 2023 |